Orbimed Genesis Gp Llc Insider Trades

Insider Trading History

Track insider trading activity for Orbimed Genesis Gp Llc. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $2.04M 38,450 shares
Last Trade
Aug 16, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$191k 38,450 shares
$4.98
$52.95
Ikena Oncology
Ikena Oncology IKNA
Director
Holding Value $32.8M 1,912,678 shares
Last Trade
Jun 22, 2022 Sale (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.93M 66,806 shares
$43.92
$17.16
ImageneBio
ImageneBio IMA
Director
Holding Value $11.5M 1,912,678 shares
Last Trade
Jun 22, 2022 Sale (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$6.01
PMV Pharmaceuticals
PMV Pharmaceuticals PMVP
Director
Holding Value $106k 87,786 shares
Last Trade
May 26, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$347k 26,253 shares
$13.21
$1.21
Edgewise Therapeutics
Edgewise Therapeutics EWTX
Director
Holding Value $524M 13,497,456 shares
Last Trade
May 18, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$995k 138,000 shares
$7.21
$38.83
Compass Therapeutics
Compass Therapeutics CMPX
Director
Holding Value $30.3M 14,690,178 shares
Last Trade
May 11, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$116k 64,700 shares
$1.79
$2.06
Compass Therapeutics
Compass Therapeutics CMPX
Director
Holding Value $30.1M 14,625,478 shares
Last Trade
May 06, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$39.1k 24,447 shares
$1.60
$2.06

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up